Cargando…

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer

The pathogenesis and cisplatin chemoresistance of ovarian cancer (OC) are still unclear. Vacuolar protein sorting‐associated 33B (VPS33B) has not been reported in OC to date. In this study, immunohistochemistry was used to detect VPS33B protein expression between OC and ovarian tissues. MTT, EdU, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Yingxia, Zeng, Zhaoyang, Deng, Yuao, Feng, Weifeng, Huang, Lun, Liu, Huiling, Lin, Jiazhi, Zhang, Chen, Fan, Yue, Liu, Longyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088924/ https://www.ncbi.nlm.nih.gov/pubmed/33788346 http://dx.doi.org/10.1111/cas.14864

Ejemplares similares

VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin
por: Liu, Zhen, et al.
Publicado: (2020)

Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression
por: Deng, Yuao, et al.
Publicado: (2017)

VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
por: Liang, Zixi, et al.
Publicado: (2019)

Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
por: Liu, Zhen, et al.
Publicado: (2011)

miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis
por: Cheng, Chao, et al.
Publicado: (2021)

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B
por: Hunter, Morag R., et al.
Publicado: (2018)

Expression of Concern: Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
Publicado: (2020)

Correction to Expression of Concern on: Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
Publicado: (2020)

Recruitment of VPS33A to HOPS by VPS16 Is Required for Lysosome Fusion with Endosomes and Autophagosomes
por: Wartosch, Lena, et al.
Publicado: (2015)

Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism
por: Dou, Lei, et al.
Publicado: (2023)

The lysosomal disease caused by mutant VPS33A
por: Pavlova, Elena V, et al.
Publicado: (2019)

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
por: Wu, Han, et al.
Publicado: (2022)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

Vps33b is crucial for structural and functional hepatocyte polarity
por: Hanley, Joanna, et al.
Publicado: (2017)

Loss of the Sec1/Munc18-family proteins VPS-33.2 and VPS-33.1 bypasses a block in endosome maturation in Caenorhabditis elegans
por: Solinger, Jachen A., et al.
Publicado: (2014)

The Sec1–Munc18 protein VPS33B forms a uniquely bidirectional complex with VPS16B
por: Liu, Richard J.Y., et al.
Publicado: (2023)

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
por: Liu, Longyang, et al.
Publicado: (2022)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function
por: Rogerson, Clare, et al.
Publicado: (2018)

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
por: Liu, Longyang, et al.
Publicado: (2019)

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance
por: Liu, Longyang, et al.
Publicado: (2023)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023)

VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer
por: Liu, Jiahao, et al.
Publicado: (2020)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020)

Metabolomics and Lipidomics Reveal the Effect of Hepatic Vps33b Deficiency on Bile Acids and Lipids Metabolism
por: Fu, Kaili, et al.
Publicado: (2019)

Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A
por: Pavlova, Elena V., et al.
Publicado: (2022)

Apigenin induces apoptosis and counteracts cisplatin-induced chemoresistance via Mcl-1 in ovarian cancer cells
por: Qi, Yuyan, et al.
Publicado: (2020)

Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis
por: Abdullah, Nada, et al.
Publicado: (2021)

ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population
por: Liu, Yi, et al.
Publicado: (2017)

A New Aberration in the VPS33B Gene Leads to Full-Symptom ARCS1
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2021)

Crystal Structures of the Sec1/Munc18 (SM) Protein Vps33, Alone and Bound to the Homotypic Fusion and Vacuolar Protein Sorting (HOPS) Subunit Vps16*
por: Baker, Richard W., et al.
Publicado: (2013)

Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy
por: Meng, Yang, et al.
Publicado: (2022)

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2021)

Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance
por: Singh, Mohan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c27ngviqm7afh0hriti105l88f